Human gene
VDR vitamin D (1,25- dihydroxyvitamin D3) receptor
1 disease group in OMIA reaches this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 1431 | Vitamin D-deficiency rickets, type II | dog | VDR | one to one | Drug |
63.2
|
| 1431 | Vitamin D-deficiency rickets, type II | domestic cat | VDR | one to one | Drug |
63.2
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| vitamin D-dependent rickets, type 2 | MONDO:0019642 | 0.82 | 392 |
Drugs
Each ChEMBL drug that acts on this gene.
| Drug | How | Latest stage |
|---|---|---|
| Alfacalcidol | agonist | Approved |
| Calcipotriene | agonist | Approved |
| Calcitriol | agonist | Approved |
| Cholecalciferol | agonist | Approved |
| Dihydrotachysterol | agonist | Approved |
| Doxercalciferol | agonist | Approved |
| Eldecalcitol | agonist | Approved |
| Ergocalciferol | agonist | Approved |
| Paricalcitol | agonist | Approved |
| Pefcalcitol | agonist | Phase 3 |
| Seocalcitol | agonist | Phase 3 |
| Becocalcidiol | agonist | Phase 2 |
| Dp001 | agonist | Phase 2 |
| Elocalcitol | agonist | Phase 2 |
| Inecalcitol | agonist | Phase 2 |
| Lunacalcipol | agonist | Phase 2 |
| Ilx23-7553 | agonist | Phase 1 |
| Calcifediol Anhydrous | agonist | Unknown |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.